Clinical Trial Update: Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating leuprolide to enhance immune function after allogeneic bone marrow transplantation has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphocytic Leukemia
• Myelodysplastic Syndrome
• Myelogenous Leukemia
• Myelomonocytic Leukemia

Drugs mentioned

• Leuprolide (Leuprolide acetate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Myelodysplastic Syndrome, Acute Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2019-04-23